Control of over-activated innate immunity;Mechanizmy kontroli odpornos̈ci wrodzonej

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 60, Issue , 2006, Pages 201-208

  Błach Olszewska, Zofia ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Adenosine; Deficiency; Innate immunity control; Innate immunity reactions; Over activation; SOCS; Tyro 3

Indexed keywords

CYTOKINE;

ANIMAL; AUTOIMMUNITY; HUMAN; IMMUNOLOGY; INFECTION; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NEOPLASM; REVIEW;

ANIMALS; AUTOIMMUNITY; CYTOKINES; ENGLISH ABSTRACT; HUMANS; INFECTION; INFLAMMATION; KILLER CELLS, NATURAL; MAJOR HISTOCOMPATIBILITY COMPLEX; NEOPLASMS;

EID: 33846083471     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Agteresch H.J., Dagnelie P.C., van der Gaast A., Stijnen T., Wilson J.H.: Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer. J. Natl. Cancer Inst., 2000; 92: 321-328
2. Ameredes B.T., Zamora R., Sethi J.M., Liu H., Kohut L.K., Gligonic A.L., Choi A.M.K., Calhoun W.J.: Alterations in nitric oxide and cytokine production with airway inflamation in the absence of IL-10. J. Immunol., 2005; 175: 1206-1213
3. Baccala R., Kono D.H., Theofilopoulos A.N.: Interferons as pathogenic effectors in autoimmunity. Immunol. Rev., 2005; 204: 9-26
4. Bieńkowska-Haba M., Liebhart J., Cembrzyńska-Nowak M.: Nitric oxide production by pulmonary leukocytes from induced sputum in patients with asthma and its effect on epithelial viability. Arch. Immunol. Ther. Exp., 2006; (w druku)
5. Błach-Olszewska Z.: Innate Immunity: cells, receptors, and signaling pathways. Arch. Immunol. Ther. Exp., 2005; 53: 245-253
6. Błach-Olszewska Z., Zaczyńska E., Kiełbiński M., Frydecka I.: Deficiency of innate immunity of leukocytes is associated with the failure of the induction of remission and survival time in patients with acute leukemia. Polish J. Environmental Studies, 2005; 14(Suppl II): 36-40
7. Carayannopoulos L.N., Yokoyama W.N.: Recognittion of infected cells by natural killer cells. Curr Op Immunol, 2004; 16: 26-33
8. Cembrzyńska-Nowak M., Liebhart J., Bieńkowska-Haba M., Liebhart E., Kulczak A., Siemieniec I., Dobek R., Dor A., Barg W., Panaszek B.: The overproduction of nitric oxide associated with neutrophilic predominance is relevant to airway mycotic infections in asthmatics undergoing prolonged glucocorticoid treatment. Cell Biol. Mol. Lett., 2005, 10: 677-687
9. Chang T.L., Vargas J.Jr., Del Portillo A., Klotman M.E.: Dual role of a-defensin-1 in anti-HIV-1 innate immunity. J Clin Invest, 2005; 115: 765-773
10. Diamond B.: Autoimmunity. Immunol. Rev., 2005; 204: 5-8
11. Elliott J., Johnston J.A.: SOCS: role in inflammation, allergy and homeostasis. Trends Immunol.2004; 25: 434-440
12. Elson C.O., Cong Y., McCracken V.J., Dimmitt R.A., Lorenz R.G., Weaver C. T.: Experimental model of inflammatory bowel disease reveal innate, adaptive and regulatory mechanisms of host dialogue with the microbiota. Immunological Reviws, 2005; 206: 260-276
13. Ferlazzo G., Munz C.: NK cell compartments and their activation by dendritic cells J. Immunol., 2004; 172: 1333-1339
14. Fujita T., Matsushita M., Endo Y.: The lectin-complement pathway-its role in innate immunity and evolution., Immunol. Rev., 2004; 198: 185-202
15. Gasser S., Orsulic S., Brown E.J., Raulet D.H.: The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature, 2005; 436: 1186-1190
16. Greenhalgh C.J., Rico-Bautista E., Lorentzon M., Thaus A.L., Morgan P.O., Willson T.A., Zervoudakis P., Metcalf D., Street I., Nicola N.A., Nash A.D., Fabri L.J., Norstedt G., Ohlsson C., Flores-Morales A., Alexander W.S., Hilton D.J.: SOCS2 negative regulates growth hormone action in vitro and in vivo. J. Clin. Invest,. 2005; 115: 397-406
17. Hasko G., Cronstein B.N. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 2004; 25: 33-39
18. Hershfield M.S.: New insight into adenosine-receptor-mediated immunosuppression and role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Eur.J.Immunol., 2005; 35: 25-30
19. Hu X., Ho H.H., Lou O., Hidaka C., Ivashkiv L.B. Homeostatitic role of interferons conferred byinhibition of IL-1-mediated inflmation and tissue destruction. J. Immunol., 2005; 175: 131-138
20. Johnson G.B., Brunn G.J., PlattJ.L.: Activation of mammalian Toll-like receptors by endogenous agonists. Crit. Rev. Immunol., 2003; 23: 15-44
21. Johnson T.R., Mertz S.E., Gitiban N., Hammond S., Legallo R., Durbin R.K., Durbin J.E.: Role for innate IFNs in determining respiratory syncytial virus immunopathology. J. Immunol., 2005; 174: 7234-7241
22. Jung D.Y., Lee H., Jung B.Y., Ock J., Lee M.S., Lee W.H., Suk K.: TLR4 but not TLR2, signals autoregulatory apoptosis of cultured microglia: A critical role of IFNb as a decision marker. J. Immunol., 2005; 174: 6467-6476
23. Ku C.L., Yang K., Bustamate J., Puel A., von Bernuth H., Santos O.F., Lawrence T., Chang H.H., Al-Mousa H., Picard C., Casanova J.L.: Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol. Rev., 2005; 203: 10-20
24. LeBourder E., Rey-Nores J.E.,Rushmere N.K., Grigorov M., Lawn S.D., Affolter M., Griffin G.E., Ferrara P., Schriffrin E.J., Morgan B.P., Labeta M.O.: Soluble forms of toll-like receptor (TLR) 2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immunol., 2003; 171: 6680-6689
25. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., Vartanian T.: Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. USA, 2003; 100: 8514-8519
26. Lemke G., Lu Q.: Macrophage regulation by Tyro-3 family receptors. Curr. Opin. Immunol., 2003; 15: 31-36
27. Liberatore G. T., Jackson-Levis V., Vukosavic S., Mandir A.S., Vila M., McAuliffe W.G., Dawson V.L., Dawson T.M., Przedborski S.: Inducible nitric oxide synthase stimulates dopaminergic neurodegradation in MTPT model of Parkinson disease. Nat. Med. 1999; 5: 1403-1409
28. Lighvani S., Huang X., Trivedi P.P., Swanborg R.H., Hazlett L.D.: Substance P regulates natural killer cell interferon g production and resistance to Psudomonas aeruginosa infection. Eur. J. Immunol., 2005; 35: 1567-1575
29. Lu J., Teh C., Kishore U., Reid K. B.: Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim. Biophys. Acta, 2002; 1572: 387-400
30. Lu Q., Lemke G.: Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro3 family. Science, 2001; 293: 306-311
31. Lum J.J., Bren G., McClure R., Badley A.D.: Elimination of senescent neutrophil by TNF-related apoptosis-inducing ligand. J. Immunol., 2005; 175: 1232-1238
32. Mansell A., Smith R., Doyle S.L., Gray P., Fenner J.E., Crack P.J., Nicholson S.E., Hilton D.J., O'neill L.A., Hertzog P.J.: Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol., 2006; 7: 148-155
33. Minguet S., Huber M., Rosenkranz L., Schamel W.W.A., Reth M., Brummer T.: Adenosine and cAMP are potent inhibitors of the NFkB pathway downstream of immunoreceptors. Eur. J. Immunol., 2005; 35: 31-41
34. Murray P.J.: The primary mechanism of the IL-10-regulated antiinflamatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. USA, 2005; 102: 8686-8691
35. Nocentini G., Riccardi C.: GITR: A multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur. J. Immunol., 2005; 35: 1016-1022
36. Orzechowska B., Antoszków Z., Błach-Olszewska Z.: Individual differentiation of innate antiviral immunity in humans; role of endogenous interferons and tumor necrosis factor in immunity of leukocytes. Arch. Immunol. Ther. Exp., 2003; 51: 51-60
37. Pacheco R., Martinez-Navio J.M., Lejeune M.,Climent N., Oliva H., Gatell T., Galart T., Mallol J., Lluis C., Franco R.: CD26, adenosine deaminase and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc. Natl. Acad. Sci. USA, 2005; 102: 9583-9588
38. Paradowska E., Błach-Olszewska Z., Sender J., Jarosz W.: Antiviral nonspecific immunity of human placenta at term; possible role of endogenous tumor necrosis factors and interferons. J. Interferon Cytokines Res., 1996; 16: 941-948
39. Park S.M., Kim S., Choi J.S., Hur D.Y., Lee W.J., Lee M.S., Choe J., Lee T H.: TGFb inhibits Fas-mediated apoptosis of follicular dendritic cellline by down-regulating the expression of Fas and caspase-8: counteracting role of TGFb on TNF sentization of Fas-mediated apoptosis. J. Immunol., 2005; 174: 6169-6175
40. Poea-Guyon S., Christadoss P., LePanse R., Guyon T., DeBaets M., Wakkach A., Bidault J., Tzartos S., Berrih-Aknin S.: Effects of cytokines on acetylocholine receptor expression: implications for myasthenia gravis. J. Immunol., 2005; 174: 5941-5949
41. Prieto A.L., Weber J.L., Lai C.: Expression of the receptor protein-tyrosino kinases Tyro-3, Axl, and mer in the developing rat central nervous system. J. Comp. Neurol., 2000; 425: 295-314
42. Puel A., Picard C., Ku C.L., Smahi A., CasanowaJ.L.: Inherited disorders of NFkB-mediated immunity in men. Curr.Opin. Immunol., 2004; 16: 34-41
43. Rifkin I.R., Leadbetter E.A., Busconi L., Viglianti G., Marshak-Rothstein A.: Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunological Rev., 2005; 204: 27-42
44. Rybka K., Orzechowska B., Siemieniec I., Leszek J., Zaczyńska E., Pająk J. Błach-Olszewska Z.: Age related natural antiviral non-specific immunity of human leukocytes. Med. Sci. Monit., 2003; 9(12): BR413-BR417
45. Sochocka M., Błach-Olszewska Z.: Mechanizmy wrodzonej odpornos̈ci. Post. Hig. Med. Dos̈w., 2005; 59: 250-258
46. Stark J.L., Cross A.H.: Differential expression of suppressor of cytokine signaling-1 and-3 and related cytokines in central nervous system during remitting versus non-remitting forms of experimental autoimmune encephalomyelitis. Int. Immunol., 2006; 18: 347-353
47. Strieter R.M., Keane M.P.: Innate immunity dictates cytokine polarization relevant to the development of pulmonary fibrosis. J.Clin. Invest., 2004; 114: 165-168
48. Swennen E.L., Bast A., Dagnelie P.C. Immunoregulatory effect of adenosine 5'-triphosphate on cytokine release from stimulated whole blood. Eur.J.Immunol., 2005; 35: 852-858
49. Takase H., Yu C.R., Liu X., Fujimoto C., Gery I., Egwuagu C.E.: Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uvenitis (EAU): potential neuroprotective role of SOCS proteins. J. Neuroimmunol., 2005; 168:118-127
50. Tan J.C., Rabkin R.: Suppressors of cytokine signaling in health and disease. Pediatr. Nephrol., 2005; 20: 567-575
51. Tanga F.Y., Nutile-McMenemy N., DeLeo J.A.: The CNS role of Tolllike receptor 4 in innate neuroimmunity and painful neuropathy., 2005; 102: 5856-5861
52. Townsend K.P., Town T., Mori T. Lue L.F., Shytle D., Sanberg P.R., Morgan D., Fernandez F., Flavell R.A., Tan J.: CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid b-peptide. Eur. J. Immunol., 2005; 35: 901-910
53. Wang H., Chen Y., Ge Y., Ma P., Ma Q., Ma J., Wang H., Xue S., Han D.: Immunosuppression of Tyro3 family receptors, Tyro 3, Axl, and Mer and their ligand Gas 6 in postnatal developing mouse testis. J. Histochem. Cytochem., 2005; 53: 1355-1364
54. Wong C.C., Lee W.M.: The proximal cis-acting elements Sp1, Sp3 and E2F regulate mouse mer gene transcription in Sertoli cells. Eur. J. Biochem., 2002; 269: 3789-3800
55. Yadav A., Kalita A., Dhillon S., Banerjee K. JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3. J. Biol. Chem., 2005; 280: 31830-31840
56. Zaczyńska E., Błach-Olszewska Z.: Effect of Cyclosporine A on the non-specific innate antiviral immunity of mice. Arch.Immunol. Ther. Exp., 2001; 49(Suppl.1): S53-S57
57. Zaczyńska E., Błach-Olszewska Z., Gejdel E.: Production of cytokines with antiviral activity by endothelial cells. J. Interferon Cytokines Res., 1995; 15: 811-814
58. Zaczyńska E., Magott-Procelewska M., Rybka K., Siemieniec I., Błach-Olszewska Z., Klinger M.: Innate antiviral immunity is not impaired in patients with chronic renal failure on hemodialysis. Nephron Clin. Pract., 2005; 101: c207-c210
59. Zitvogel L.: Dendritic and natural killer cells cooperate in the controlswith of innate immunity. J. Exp. Med., 2002; 195: F9-F14